Delcath Systems, Inc. (DCTH)

Oncternal Therapeutics Revenue

Delcath Systems had revenue of $19.78M in the quarter ending March 31, 2025, with 530.26% growth. This brings the company's revenue in the last twelve months to $53.85M, up 1,068.87% year-over-year. In the year 2024, Delcath Systems had annual revenue of $37.21M with 1,701.69% growth.

• Revenue (ttm): $53.85M
• Revenue Growth: +1,068.87%
• P/S Ratio: 6.09
• Revenue / Employee: $560,938
• Employees: 96
• Market Cap: 360.31M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	37.21M	35.14M	1,701.69%
Dec 31, 2023	2.07M	-654.00K	-24.05%
Dec 31, 2022	2.72M	-836.00K	-23.52%
Dec 31, 2021	3.56M	1.91M	115.98%
Dec 31, 2020	1.65M	66.00K	4.18%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.